What is Quest Diagnostics Incorporated's stock symbol?
Quest Diagnostics Incorporated trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX."
How often does Quest Diagnostics Incorporated pay dividends? What is the dividend yield for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated declared a quarterly dividend on Tuesday, February 21st. Investors of record on Wednesday, April 5th will be given a dividend of $0.45 per share on Wednesday, April 19th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date is Monday, April 3rd.
Where is Quest Diagnostics Incorporated's stock going? Where will Quest Diagnostics Incorporated's stock price be in 2017?
15 brokers have issued 1 year price objectives for Quest Diagnostics Incorporated's stock. Their predictions range from $72.00 to $108.00. On average, they anticipate Quest Diagnostics Incorporated's share price to reach $89.32 in the next twelve months.
When will Quest Diagnostics Incorporated announce their earnings?
Quest Diagnostics Incorporated is scheduled to release their next quarterly earnings announcement on Wednesday, April, 19th 2017.
What are analysts saying about Quest Diagnostics Incorporated stock?
Here are some recent quotes from research analysts about Quest Diagnostics Incorporated stock:
According to Zacks Investment Research, "Quest Diagnostics’ fourth-quarter 2016 earnings exceeded the Zacks Consensus Estimate while revenues remained in line. The company has witnessed significant growth through infectious disease testing, prescription drug monitoring and wellness business. We expect these growth drivers to be active through the coming quarter as well. In this regard, over the past three months, Quest Diagnostics has traded above the Zacks categorized Medical - Outpatient and Home Healthcare industry. The upside is backed by the successful execution of the company’s strategy to grow its esoteric testing and drive profitable growth. Within prescription drug monitoring, the company currently has two new Zika tests that are awaiting FDA clearance. The company also piloted a noninvasive prenatal screening program to serve women of average risk. We are also looking forward to the company's latest alliance with Ancestry and IBM." (1/30/2017)
- Jefferies Group LLC analysts commented, "We are maintaining our Hold on DGX given our view that significant multiple expansion is unlikely from its current 10-year high P/E. That said, we do not expect its valuation to crack either given the company's stable fundamentals, the emerging opportunity with hospital labs, consistent dividend & buybacks, potential upside from US tax reform, and the composition of its shareholder base." (1/27/2017)
Who owns Quest Diagnostics Incorporated stock?
Quest Diagnostics Incorporated's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (4.92%), Bessemer Group Inc. (1.76%), Allianz Asset Management AG (1.76%), Investec Asset Management LTD (1.48%), Dimensional Fund Advisors LP (1.40%) and AQR Capital Management LLC (0.93%). Company insiders that own Quest Diagnostics Incorporated stock include Catherine T Doherty, Everett Cunningham, Jeffrey M Leiden, Jenne K Britell, John B Ziegler and Michael E Prevoznik.
Who sold Quest Diagnostics Incorporated stock? Who is selling Quest Diagnostics Incorporated stock?
Quest Diagnostics Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, FMR LLC, Two Sigma Investments LP, Paradigm Asset Management Co. LLC, Federated Investors Inc. PA, Investec Asset Management LTD, Davis Selected Advisers and Pinnacle Associates Ltd.. Company insiders that have sold Quest Diagnostics Incorporated stock in the last year include Catherine T Doherty, Everett Cunningham, Jeffrey M Leiden, Jenne K Britell and John B Ziegler.
Who bought Quest Diagnostics Incorporated stock? Who is buying Quest Diagnostics Incorporated stock?
Quest Diagnostics Incorporated's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp, Janus Capital Management LLC, Bessemer Group Inc., Asset Management One Co. Ltd., AMF Pensionsforsakring AB, Cipher Capital LP and Elkfork Partners LLC.
How do I buy Quest Diagnostics Incorporated stock?
Shares of Quest Diagnostics Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Quest Diagnostics Incorporated stock cost?
One share of Quest Diagnostics Incorporated stock can currently be purchased for approximately $95.60.